|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Department of Internal Medicine, Division of Pulmonary and Critical Care, University of Florida Health Science Center, Jacksonville, FL.
Correspondence to: Bekele Afessa, MD, FCCP, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905; e-mail: Afessa.bekele{at}Mayo.edu
Study objective: To describe the clinical course and prognostic factors in patients with HIV admitted to the ICU.
Design: Prospective, observational.
Setting: A university-affiliated medical center.
Methods: We included 169 consecutive ICU admissions, from April 1995 through March 1999, of 141 adults with HIV. Data collected included APACHE (acute physiology and chronic health evaluation) II score, CD4+ lymphocyte count, serum albumin level, in-hospital mortality, and the development of organ failure, systemic inflammatory response syndrome (SIRS), and ARDS.
Results: The ICU admission rate of hospitalized patients with HIV infection was 12%. The most common reason for ICU admission was respiratory failure, occurring in 65 patient admissions. Mechanical ventilation was required in 91 admissions (54%), ARDS developed in 37 admissions (22%), Pneumocystis carinii pneumonia was diagnosed in 24 admissions (14%), and SIRS developed in 126 admissions (75%). One or more organ failures developed in 131 admissions (78%). The actual and predicted mortality rates were 29.6% and 45.2%, respectively, with a standardized mortality ratio of 0.65. The most frequent immediate cause of death was bacterial infection. The CD4+ lymphocyte count (median, 27.5 cells/µL vs 59 cells/µL; p = 0.0310) and serum albumin level (median 2.2 g/dL vs 2.6 g/dL; p = 0.0355) of nonsurvivors were lower and the APACHE II score (median, 30 vs 21; p < 0.0001) was higher, compared to those of survivors. A higher APACHE II score (odds ratio [OR], 1.11; 95% confidence interval [CI], 1.05 to 1.16) and a transfer from another hospital ward (OR, 3.03; 95% CI, 1.20 to 7.68) were independently associated with increased mortality. The median number of organ failures that developed in survivors was one, compared to four in nonsurvivors (p < 0.0001).
Conclusions: The outcome of HIV-infected patients admitted to the ICU has improved over the years. The CD4 count does not correlate with in-hospital mortality. Higher APACHE II scores and a transfer from another hospital ward are associated with a poor outcome.
Key Words: AIDS APACHE ARDS HIV ICU admission organ failure outcome Pneumocystis carinii pneumonia respiratory failure systemic inflammatory response syndrome
This article has been cited by other articles:
![]() |
R F Miller, E Allen, A Copas, M Singer, and S G Edwards Improved survival for HIV infected patients with severe Pneumocystis jirovecii pneumonia is independent of highly active antiretroviral therapy Thorax, August 1, 2006; 61(8): 716 - 721. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Khouli, A. Afrasiabi, M. Shibli, R. Hajal, C. R. Barrett, and P. Homel Outcome of Critically Ill Human Immunodeficiency Virus-Infected Patients in the Era of Highly Active Antiretroviral Therapy J Intensive Care Med, December 1, 2005; 20(6): 279 - 285. [Abstract] [PDF] |
||||
![]() |
R J Boyton, D M Mitchell, and O M Kon The pulmonary physician in critical care * Illustrative case 5: HIV associated pneumonia Thorax, August 1, 2003; 58(8): 721 - 725. [Full Text] [PDF] |
||||
![]() |
A. Morris, J. Creasman, J. Turner, J. M. Luce, R. M. Wachter, and L. Huang Intensive Care of Human Immunodeficiency Virus-infected Patients during the Era of Highly Active Antiretroviral Therapy Am. J. Respir. Crit. Care Med., August 1, 2002; 166(3): 262 - 267. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Afessa, I. Morales, and J. D. Cury Clinical Course and Outcome of Patients Admitted to an ICU for Status Asthmaticus Chest, November 1, 2001; 120(5): 1616 - 1621. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |